| Bioactivity | KRAS inhibitor-40 (Compound 41) is a KRAS inhibitor that interferes with the KRAS G12C-BRAF complex. KRAS inhibitor-40 inhibits the ERK phosphorylation of KRAS downstream signaling pathway. KRAS inhibitor-40 can inhibit the proliferation of tumor cells with different KRAS mutation types and has antitumor activity[1]. |
| CAS | 3059496-56-6 |
| Formula | C53H68ClF4N9O8S |
| Molar Mass | 1102.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jianguo Chen, et al. Tricyclic compounds for the treatment of cancer. WO2024208934A1. 2024-10-10. |
KRAS inhibitor-40
CAS: 3059496-56-6 F: C53H68ClF4N9O8S W: 1102.67
KRAS inhibitor-40 (Compound 41) is a KRAS inhibitor that interferes with the KRAS G12C-BRAF complex.KRAS inhibitor-40 in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.